AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 47 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 2.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $210,126 | -7.3% | 137,337 | 0.0% | 0.00% | – |
Q2 2023 | $226,606 | +107.0% | 137,337 | +43.0% | 0.00% | – |
Q1 2023 | $109,482 | -36.8% | 96,037 | -50.0% | 0.00% | – |
Q4 2022 | $173,270 | +54.7% | 192,074 | +100.0% | 0.00% | – |
Q3 2022 | $112,000 | +83.6% | 96,037 | 0.0% | 0.00% | – |
Q2 2022 | $61,000 | -75.7% | 96,037 | 0.0% | 0.00% | – |
Q1 2022 | $251,000 | -26.0% | 96,037 | +10.3% | 0.00% | – |
Q4 2021 | $339,000 | +11.1% | 87,077 | +24.6% | 0.00% | – |
Q3 2021 | $305,000 | +10.1% | 69,877 | 0.0% | 0.00% | – |
Q2 2021 | $277,000 | -83.5% | 69,877 | -78.4% | 0.00% | – |
Q1 2021 | $1,683,000 | -0.1% | 323,643 | +2.8% | 0.00% | – |
Q4 2020 | $1,685,000 | +19.8% | 314,891 | +8.6% | 0.00% | – |
Q3 2020 | $1,407,000 | +0.3% | 289,844 | +0.4% | 0.00% | – |
Q2 2020 | $1,403,000 | +315.1% | 288,730 | +490.0% | 0.00% | – |
Q1 2019 | $338,000 | +26.1% | 48,935 | +14.9% | 0.00% | – |
Q4 2018 | $268,000 | +3.1% | 42,580 | +187.7% | 0.00% | – |
Q3 2018 | $260,000 | – | 14,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 11,503,294 | $55,848,000 | 77.67% |
Bracebridge Capital, LLC | 428,571 | $2,083,000 | 0.33% |
Oak Grove Capital LLC | 89,000 | $432,000 | 0.20% |
Perceptive Advisors | 1,750,000 | $8,496,000 | 0.12% |
Virtu Financial LLC | 117,206 | $569,000 | 0.10% |
WEDBUSH SECURITIES INC | 103,240 | $501,000 | 0.05% |
J. Goldman & Co LP | 117,600 | $571,000 | 0.04% |
Engineers Gate Manager LP | 68,300 | $332,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 118,900 | $577,000 | 0.01% |
Brandywine Global Investment Management, LLC | 137,029 | $666,000 | 0.01% |